BMY
40
-5
MAR
57
3
WFC
58
8
DFS
64
4
ILMN
31
4
LUV
45
3
LEN
21
3
ALL
37
3
KLAC
45
3
SNA
56
3
BLK
47
3
IP
53
3
EOG
28
2
ICE
53
5
NVDA
52
5
A
43
2
APA
30
5
MS
64
3
TXT
46
4
HBAN
47
7
BMY
40
-5
MAR
57
3
WFC
58
8
DFS
64
4
ILMN
31
4
LUV
45
3
LEN
21
3
ALL
37
3
KLAC
45
3
SNA
56
3
BLK
47
3
IP
53
3
EOG
28
2
ICE
53
5
NVDA
52
5
A
43
2
APA
30
5
MS
64
3
TXT
46
4
HBAN
47
7
Financhill
Back

Canopy Growth Vs. Novo Nordisk AS Industry Stock Comparison

Sell
24

CGC
Canopy Growth

Last Price:
$2.82
Seasonality Move:
3.71%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Sell
24
Canopy Growth (CGC) is a Sell

Is Canopy Growth a Buy, Sell or Hold?

  • The current Canopy Growth [CGC] share price is $2.83. The Score for CGC is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • CGC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CGC Stock Price Chart

What is Canopy Growth's stock price today?

  • The Canopy Growth share price today is $2.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CGC is experiencing slight buying pressure.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

CGC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 28.83 Sell
Chaikin Money Flow: 3928919 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.12 - 3.92) Sell
Bollinger Bands (100): (3.64 - 5.76) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

CGC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3 Sell
20-day SMA: 3.45 Sell
50-day SMA: 4.06 Sell
200-day SMA: 6.2 Sell
8-day EMA: 3.01 Sell
20-day EMA: 3.36 Sell
50-day EMA: 3.93 Sell
200-day EMA: 5.76 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

Canopy Growth Earnings Growth & CGC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.78 per share, and a decrease next year of $0.24 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

Canopy Growth Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):